InvestorsHub Logo
Followers 155
Posts 2623
Boards Moderated 0
Alias Born 01/29/2004

Re: Steady_T post# 317057

Thursday, 06/24/2021 10:31:19 AM

Thursday, June 24, 2021 10:31:19 AM

Post# of 460718
Only one thing counts.

The FDA holds all the cards. Trial results are all that matters.


Any and all of us can go on and on about the wonderful benefits of blarcamesine, both as to eventual AVXL share prices and wonderful therapies for diseased individuals. As a biologist, I tend to tell about the unique molecular biology of the Anavex sigma-1 receptor activators. Others tell about the number AVXL shares and so forth. Lots of info on Biogen and Aduhelm.

But the stark reality is this, "Trial results are all that matters."

Nuf said.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News